Indication
Reactive Arthritis
1 clinical trial
1 product
1 drug
Clinical trial
A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg Daily or 550 mg Twice Daily) for Chemoprophylaxis Against Travelers' Diarrhea (TD) Among Active Duty Deployed U.S. and British Military PersonnelStatus: Completed, Estimated PCD: 2019-07-01
Product
RifaximinDrug
Varlilumab